BHVN: Biohaven Ltd Financial Statements
Balance sheet, income statement, and cash flow statements for Biohaven Ltd (BHVN).
$3.78B Market Cap.
BHVN Market Cap. (MRY)
BHVN Shares Outstanding (MRY)
BHVN Assets (MRY)
Total Assets
$615.11M
Total Liabilities
$191.67M
Total Investments
$386.86M
BHVN Income (MRY)
Revenue
$0
Net Income
-$846.42M
Operating Expense
$885.11M
BHVN Cash Flow (MRY)
CF Operations
-$582.45M
CF Investing
-$244.97M
CF Financing
$677.77M
BHVN Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $615,107,000 (19.85%) | $513,212,000 (-22.45%) | $661,783,000 (365.84%) | $142,061,000 (27.41%) |
Assets Current | $538,472,000 (21.70%) | $442,446,000 (-24.62%) | $586,968,000 (519.01%) | $94,823,000 (5.65%) |
Assets Non-Current | $76,635,000 (8.29%) | $70,766,000 (-5.41%) | $74,815,000 (58.38%) | $47,238,000 (117.26%) |
Goodwill & Intangible Assets | $19,790,000 (0.00%) | $19,790,000 (0.00%) | $19,790,000 (0.00%) | $19,790,000 (0%) |
Shareholders Equity | $423,436,000 (-1.06%) | $427,975,000 (-20.56%) | $538,771,000 (1453.06%) | $34,691,000 (106.73%) |
Property Plant & Equipment Net | $17,320,000 (0.75%) | $17,191,000 (-1.83%) | $17,512,000 (34.60%) | $13,010,000 (71.66%) |
Cash & Equivalents | $99,134,000 (-60.09%) | $248,402,000 (3.46%) | $240,089,000 (215.67%) | $76,057,000 (-7.82%) |
Accumulated Other Comprehensive Income | $79,000 (221.54%) | -$65,000 (-122.89%) | $284,000 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $386,857,000 (189.96%) | $133,417,000 (-48.78%) | $260,464,000 (0%) | $0 (0%) |
Investments Current | $386,857,000 (189.96%) | $133,417,000 (-48.78%) | $260,464,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $18,029,000 (15.74%) | $15,577,000 (-66.07%) | $45,915,000 (861.57%) | $4,775,000 (73.13%) |
Accumulated Retained Earnings (Deficit) | -$1,345,714,000 (-169.52%) | -$499,292,000 (-447.93%) | -$91,124,000 (0%) | $0 |
Tax Assets | $0 (0%) | $13,252,000 (-71.28%) | $46,139,000 (365.53%) | $9,911,000 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $32,782,000 (18.91%) | $27,569,000 (-9.85%) | $30,581,000 (993.35%) | $2,797,000 (0%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $32,782,000 (18.91%) | $27,569,000 (-9.85%) | $30,581,000 (993.35%) | $2,797,000 (0%) |
Total Liabilities | $191,671,000 (124.87%) | $85,237,000 (-30.71%) | $123,012,000 (159.68%) | $47,370,000 (36.44%) |
Liabilities Current | $154,226,000 (178.27%) | $55,423,000 (-38.43%) | $90,021,000 (114.67%) | $41,935,000 (40.36%) |
Liabilities Non-Current | $37,445,000 (25.60%) | $29,814,000 (-9.63%) | $32,991,000 (507.01%) | $5,435,000 (12.27%) |
BHVN Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $89,240,000 (42.17%) | $62,770,000 (-52.03%) | $130,860,000 (249.76%) | $37,414,000 (133.17%) |
Research & Development Expense | $795,871,000 (113.21%) | $373,281,000 (-14.60%) | $437,072,000 (140.83%) | $181,486,000 (84.32%) |
Operating Expenses | $885,111,000 (102.98%) | $436,051,000 (-23.22%) | $567,932,000 (159.45%) | $218,900,000 (91.17%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $735,000 (153.15%) | -$1,383,000 (-415.75%) | $438,000 (-67.94%) | $1,366,000 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$846,422,000 (-107.37%) | -$408,168,000 (28.43%) | -$570,279,000 (-166.74%) | -$213,796,000 (-80.16%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$846,422,000 (-107.37%) | -$408,168,000 (28.43%) | -$570,279,000 (-166.74%) | -$213,796,000 (-80.16%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$846,422,000 (-107.37%) | -$408,168,000 (28.43%) | -$570,279,000 (-166.74%) | -$213,796,000 (-80.16%) |
Weighted Average Shares | $91,234,337 (28.14%) | $71,200,527 (59.14%) | $44,741,316 (13.63%) | $39,375,944 (0.00%) |
Weighted Average Shares Diluted | $91,234,337 (28.14%) | $71,200,527 (59.14%) | $44,741,316 (13.63%) | $39,375,944 (0.00%) |
Earning Before Interest & Taxes (EBIT) | -$845,687,000 (-106.49%) | -$409,551,000 (28.13%) | -$569,841,000 (-168.25%) | -$212,430,000 (-79.01%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$885,111,000 (-102.98%) | -$436,051,000 (23.22%) | -$567,932,000 (-159.45%) | -$218,900,000 (-91.17%) |
BHVN Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$244,974,000 (-288.69%) | $129,830,000 (142.60%) | -$304,790,000 (-32387.08%) | $944,000 (135.00%) |
Net Cash Flow from Financing | $677,774,000 (219.84%) | $211,908,000 (-72.39%) | $767,597,000 (454.43%) | $138,447,000 (-9.06%) |
Net Cash Flow from Operations | -$582,453,000 (-75.58%) | -$331,725,000 (-11.43%) | -$297,689,000 (-104.12%) | -$145,840,000 (-92.00%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$149,578,000 (-1671.86%) | $9,516,000 (-94.25%) | $165,547,000 (2667.02%) | -$6,449,000 (-108.76%) |
Net Cash Flow - Business Acquisitions and Disposals | $391,000 (0%) | $0 (0%) | -$39,000,000 (-2172.26%) | $1,882,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$241,316,000 (-281.61%) | $132,878,000 (151.16%) | -$259,716,000 (0%) | $0 (0%) |
Capital Expenditure | -$4,049,000 (-32.84%) | -$3,048,000 (49.82%) | -$6,074,000 (-547.55%) | -$938,000 (65.22%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $677,666,000 (173.34%) | $247,920,000 (-12.78%) | $284,255,000 (71863.29%) | $395,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $75,000 (115.09%) | -$497,000 (-215.85%) | $429,000 (0%) | $0 (0%) |
Share Based Compensation | $71,963,000 (149.98%) | $28,787,000 (-85.13%) | $193,556,000 (194.88%) | $65,639,000 (122.51%) |
Depreciation Amortization & Accretion | $7,855,000 (13.64%) | $6,912,000 (398.70%) | $1,386,000 (-0.50%) | $1,393,000 (1834.72%) |
BHVN Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -237.70% (-129.66%) | -103.50% (47.96%) | -198.90% (76.06%) | -830.70% |
Return on Average Assets (ROAA) | -159.20% (-97.03%) | -80.80% (43.06%) | -141.90% (15.84%) | -168.60% |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -336.80% (-106.12%) | -163.40% (49.89%) | -326.10% (95.25%) | -6861.40% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -4.03 (46.11%) | -7.47 (-585.86%) | -1.09 | - |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 8.92 (11.17%) | 8.02 (356.95%) | 1.76 | - |
Debt to Equity Ratio (D/E) | 0.45 (127.64%) | 0.2 (-12.72%) | 0.23 (-83.30%) | 1.36 (-34.03%) |
Earnings Per Share (EPS) | -9.28 (-61.95%) | -5.73 (55.06%) | -12.75 (-134.81%) | -5.43 (-80.40%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -6.43 (-36.73%) | -4.7 (30.74%) | -6.79 (-82.11%) | -3.73 (-86.59%) |
Book Value Per Share (BVPS) | 4.64 (-22.79%) | 6.01 (-50.08%) | 12.04 (1266.86%) | 0.88 (106.81%) |
Tangible Assets Book Value Per Share (TABVPS) | 6.53 (-5.84%) | 6.93 (-51.70%) | 14.35 (362.13%) | 3.1 (9.64%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (50.00%) | -8 (-300.00%) | -2 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.44 (46.68%) | -8.32 (-428.38%) | -1.57 | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 |
Current Ratio | 3.49 (-56.27%) | 7.98 (22.44%) | 6.52 (188.37%) | 2.26 (-24.73%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$586,502,000 (-75.19%) | -$334,773,000 (-10.21%) | -$303,763,000 (-106.95%) | -$146,778,000 (-86.61%) |
Enterprise Value (EV) | $3,717,837,888 (10.96%) | $3,350,561,477 (274.19%) | $895,406,389 | - |
Earnings Before Tax (EBT) | -$845,687,000 (-106.49%) | -$409,551,000 (28.13%) | -$569,841,000 (-168.25%) | -$212,430,000 (-79.01%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$837,832,000 (-108.09%) | -$402,639,000 (29.17%) | -$568,455,000 (-169.36%) | -$211,037,000 (-77.95%) |
Invested Capital | $374,739,000 (72.56%) | $217,166,000 (-36.59%) | $342,464,000 (4739.80%) | $7,076,000 (900.45%) |
Working Capital | $384,246,000 (-0.72%) | $387,023,000 (-22.12%) | $496,947,000 (839.62%) | $52,888,000 (-11.68%) |
Tangible Asset Value | $595,317,000 (20.65%) | $493,422,000 (-23.14%) | $641,993,000 (425.06%) | $122,271,000 (9.66%) |
Market Capitalization | $3,776,915,888 (9.99%) | $3,434,000,477 (262.97%) | $946,074,389 | - |
Average Equity | $356,157,250 (-9.69%) | $394,373,500 (37.54%) | $286,731,000 (1014.12%) | $25,736,000 |
Average Assets | $531,700,750 (5.22%) | $505,301,250 (25.72%) | $401,922,000 (217.02%) | $126,780,000 |
Invested Capital Average | $251,081,250 (0.17%) | $250,647,250 (43.42%) | $174,770,000 (5545.03%) | $3,096,000 |
Shares | 101,122,246 (26.03%) | 80,233,656 (17.71%) | 68,160,979 (90.27%) | 35,822,511 |